MAPK3 and breast cancer: In the ERα-negative breast cancer cells (MDA-MB-468 and MDA-MB-436 cells), rapid activation of ERK1/2 (<30min) was induced by G1 treatment via GPER/EGFR/ERK signaling, leading to cell proliferation and cell migration [58].